C12N 2770/40034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/40034 (Use of virus or viral component as vaccine) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 7
- Assignees
- 3
- Inventors
- 15
- Latest grant
- 24 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
By publication year.
Recent patents
- Virus and antigen purification and conjugation26 Sep 2024US 2024/0316188 A1Kbio Holdings Limited
- Virus and antigen purification and conjugation23 Feb 2023US 2023/0056944 A1Kbio Holdings Limited
- Virus and antigen purification and conjugation16 Apr 2020US 2020/0113999 A1Kbio Holdings Limited
- Cancer immunotherapy using virus particles5 Mar 2020US 2020/0069752 A1Case Western Reserve University
- Papaya mosaic virus and virus-like particles in cancer therapy11 Aug 2016US 2016/0228541 A1Folia Biotech Inc.
Most cited
By later US patents